Open an Account
search icon
3
NOTIFICATIONS
Best Algo trading app in India
Bigul

Dishman Carbogen Amcis Ltd - 540701 - Closure of Trading Window

 We would like to inform that as per Code of Conduct for prevention of Insider Trading adopted by the Company under SEBI (Prohibition of Insider Trading) Regulations, 2015, as amended from time to time, the Trading Window for dealing in securities/ shares of the Company shall remain closed with effect from 1st April, 2022 for all the Directors, Designated Persons and their immediate relative(s). The Trading Window will be opened 48 hours after the announcement of the Audited Financial Results of the Company for the quarter and year ended 31st March, 2022.
31-03-2022
Bigul

Dishman Carbogen Amcis Ltd - 540701 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

 Pursuant to the Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that Mr. Mark Griffiths (DIN: 06981744) shall be retiring with effect from 1st April, 2022 in the capacity as a Director - Global Marketing & Strategy and member of the Board of Directors of Dishman Carbogen Amcis Limited ('DCAL'). Further, his role as CEO of CARBOGEN AMCIS entities, Company's wholly owned subsidiaries is being handed over to Mr. Pascal Villemagne. Mr. Villemagne has been with the Company for 11 years now and is perfectly placed to take the team forward to an exciting future. In this regard, please find enclosed herewith Press Release. The information required pursuant to Schedule Ill of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 are mentioned in the attached letter.
30-03-2022
Bigul

Dishman Carbogen Amcis Ltd - 540701 - Announcement under Regulation 30 (LODR)-Retirement

 Pursuant to the Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that Mr. Mark Griffiths (DIN: 06981744) shall be retiring with effect from 1st April, 2022 in the capacity as a Director - Global Marketing & Strategy and member of the Board of Directors of Dishman Carbogen Amcis Limited ('DCAL'). Further, his role as CEO of CARBOGEN AMCIS entities, Company's wholly owned subsidiaries is being handed over to Mr. Pascal Villemagne. Mr. Villemagne has been with the Company for 11 years now and is perfectly placed to take the team forward to an exciting future. In this regard, please find enclosed herewith Press Release. The information required pursuant to Schedule Ill of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 are mentioned in the attached letter.
30-03-2022
Bigul

Dishman Carbogen Amcis Ltd - 540701 - Disclosure Pursuant To Regulation 30 Of SEBI (LODR) Regulations, 2015 ('Listing Regulations') Pertaining To Investor Relation Agency

 Pursuant to Regulation 30 of Listing Regulations, this is to inform that as intimated earlier by the Company on 25th June, 2020, the Company has entered into Investor Relations Support Service Agreement with Christensen Investor Relations (India) Private Limited ('Christensen') for providing Investor Relations Support Services with effect from 24th June, 2020. In this regard, we would like to inform that Christensen has informed us that Ernst & Young LLP has entered into an agreement with Christensen Investor Relations (India) Private Limited to acquire its Investor Relations Advisory services business in India. Accordingly, now Ernst & Young LLP is the Company's Investor Relation Agency for providing Investor Relations Support Services. The requisite details in terms of Regulation 30 of Listing Regulations are mentioned in the attached file.
15-03-2022

Dishman Carboge Consolidated December 2021 Net Sales at Rs 562.08 crore, up 19.96% Y-o-Y

 NULL
08-02-2022

Earnings Call for Q3FY22 of Dishman Carbogen Amcis

 Conference Call with Dishman Carbogen Amcis Management and Analysts on Q3FY22 Performance and Outlook. Listen to the full earnings transcript.
04-02-2022
Bigul

Q3FY22 Quarterly Result Announced for Dishman Carbogen Amcis Ltd.

 Pharmaceuticals company Dishman Carbogen Amcis declares Q3FY22 result: Net Revenue at Rs 5,620.8 mn in Q3 FY22 up by 20.0% YoY CRAMS revenue increased by 34.3% YoY primarily due to: CRAMS India revenue increased by 97.9% due to steady increase in operations from the manufacturing plants located in India. CRAMS - Switzerland, France & China revenue increased by 31.5% due to higher commercial revenue. Marketable Molecules revenue decreased by 15.9% YoY primarily due to: Carbogen Amcis BV revenue decreased by 15.6% due to lower supplies of Vitamin D analogues. Others revenue decreased by 16.2% due to lesser focus on the lower margin molecules. EBITDA Margin at 19.5% in Q3 FY22 compared to 13.4% in Q3 FY21 due to: Higher CRAMS revenue, which is a high margin business segment. Net Debt excluding lease liabilities was USD 122 mn as on December 30, 2021 (USD 101 mn as on September 30, 2021). Capital expenditure for Q3 FY22 was approximately USD 19.93 mn. Result PDF
04-02-2022
Bigul

Dishman Carbogen Amcis Ltd - 540701 - Announcement under Regulation 30 (LODR)-Investor Presentation

 Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosures Requirements) Regulations, 2015, kindly find enclosed herewith Presentation on financial result for the third quarter and nine months ended 31st December, 2021 to be made to Analyst and Investors. The aforesaid presentation is also being hosted on the website of the Company, www.imdcal.com in accordance with the Regulation 46 of the SEBI (Listing Obligations and Disclosures Requirements) Regulations, 2015.
04-02-2022
Bigul

Dishman Carbogen Amcis Ltd - 540701 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

 This is to inform that pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosures Requirements) Regulations, 2015, the Company has arranged Investor Call on Friday, 4th February, 2022 at 16:00 hrs (IST) to discuss the financial result and performance of the Company for the quarter and nine months ended on 31st December, 2021.
03-02-2022
Bigul

Dishman Carbogen Amcis Ltd - 540701 - UN-AUDITED FINANCIAL RESULTS AND STATUTORY AUDITORS' LIMITED REVIEW REPORT FOR THE THIRD QUARTER AND NINE MONTHS ENDED 31/12/2021

 As per Regulation 30 and 33 of SEBI (LODR) Regulations, 2015 we hereby inform that a Meeting of the Board of Directors of the Company was held today i.e. on Thursday, the 3rd day of February, 2022 which was commenced at 1:30 P.M. and concluded at 05:20 P.M., inter alia, to consider and take on record the Un-audited Financial Results of the Company for the quarter and nine months ended on 31st December, 2021 along with Statutory Auditors' Limited Review Report dated 3rd day of February, 2022 issued by M/s. T R Chadha & Co. LLP, Chartered Accountants, in respect of the Un-audited Financial Results of the Company for the quarter and nine months ended on 31st December, 2021, prepared in terms of Regulation 33 of SEBI (LODR) Regulations, 2015. At the said Board Meeting the said Un-audited Financial Results alongwith Limited Review Report were adopted and approved, which are attached herewith.
03-02-2022
Next Page
Close

Let's Open Free Demat Account